Gedea Biotech
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$5.03M
Company Overview
Gedea Biotech is a biotechnology company that develops pHyph, an antibiotic-free treatment for vaginal infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gedea Biotech Comparables
Compare Gedea Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yaso Therapeutics, Inc. | 79% | |
| Osel Inc. | 77% | |
| Coologics | 77% |
Gedea Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| VC Round | Nov 15, 2023 | ||||
| VC Round | May 24, 2023 | ||||
| Grant | Apr 4, 2023 | ||||
| VC Round | Oct 28, 2021 | ||||
Grant | Dec 11, 2019 |
Key People
Founding team and executive leadership
Gedea Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Almi Invest AB | Seed |
| Vinnova | Grant |
| Porte-Monnaie Venture | Seed |
| Swelife | Grant |
| LU Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 182% MoM, reaching 1.3K.
- Jan 27, 2026
Julie Waras Brogren appointed as new CEO.
Gedea Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Gedea Biotech's valuation, stock price, and market status.
Is GEDEA BIOTECH a public or private company?
GEDEA BIOTECH is a private company.
What is the current stock price of GEDEA BIOTECH?
GEDEA BIOTECH is a private company with no public stock price. No recent secondary market data is available.
How much is GEDEA BIOTECH worth (valuation)?
Valuation information for GEDEA BIOTECH is not publicly available.
Can I buy GEDEA BIOTECH stock?
GEDEA BIOTECH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GEDEA BIOTECH's last funding round?
GEDEA BIOTECH's most recent funding round was Grant on February 29, 2024.
Who are the main investors in GEDEA BIOTECH?
Key investors in GEDEA BIOTECH include European Innovation Council, Vinnova, Swelife.
Will GEDEA BIOTECH IPO soon?
No public IPO plans have been announced for GEDEA BIOTECH.
How can I track GEDEA BIOTECH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GEDEA BIOTECH's secondary market activity and sign up for updates.